Literature DB >> 6802814

Glycosphingolipid biosynthesis through asialogangliosides in rat bone marrow cells.

T Taki, R Kamada, M Matsumoto.   

Abstract

Glycolipid biosynthesis in rat bone marrow cells has been studied with reference to four kinds of glycosyltransferases catalyzing the transfer of N-acetylgalactosamine, galactose, N-acetylneuraminic acid, and fucose to each glycolipid acceptor. It was demonstrated that glycosyltransferase activities which synthesize galactosylglucosylceramide (CDH) from glucosylceramide (CMH), N-acetylgalactosaminylgalactosylglucosylceramide (GA2) from CDH, galactosyl-N-acetylgalactosaminylgalactosylglucosylceramide (GA1) from GA2 and N-acetylneuraminylgalactosyl-N-acetylgalactosaminylgalactosylglucosylceramide (Gm1b) from GA1 were all present in rat bone marrow cell homogenate. Fucosyltransferase activity catalyzing the transfer of fucose from GDP-fucose to GA1 was also recognized in the cell homogenate. Neutral glycolipid extracted from rat bone marrow cells was analyzed by thin layer chromatography and glycosidase treatments. The presence of glycolipids corresponding to GA2, GA1 and fucolipid was demonstrated. From these results, it was concluded that the biosynthesis of glycolipid through asialogangliosides is a major biosynthetic route in rat bone marrow cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802814     DOI: 10.1093/oxfordjournals.jbchem.a133739

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  Both GA2, GM2, and GD2 synthases and GM1b, GD1a, and GT1b synthases are single enzymes in Golgi vesicles from rat liver.

Authors:  G Pohlentz; D Klein; G Schwarzmann; D Schmitz; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 2.  Bio-recognition and functional lipidomics by glycosphingolipid transfer technology.

Authors:  Takao Taki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.